Intravitreal bevacizumab injection for central serous chorioretinopathy.
Ian Y H
IY
Wong
Simon C Y
SC
Koo
Clement W N
CW
Chan
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D056965:Injections, Intraocular; D047748:Pituitary ACTH Hypersecretion / Q000150:complications; D013256:Steroids / Q000627:therapeutic use; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D013256:Steroids; D000068258:Bevacizumab